Abstract
The findings and course in a 55-year-old Black man with thyrotoxic periodic paralysis are described. This disorder appears to have a strong predilection for Orientals (∼ 90% of reported cases) with occasional reports in Caucasians and only one previous description in a Black. HLA phenotyping of the reported patient demonstrated neither of the two genetic markers previously noted among Chinese with thyrotoxic periodic paralysis, indicating that these haplotypes do not serve as markers for the disorder in Blacks.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Noguchi A., Kuma S., Kuma K., Ito T. The association of periodic paralysis and hyperthyroidism in Japan. J. Clin. Endocrinol. Metab. 17: 1454, 1957.
McFadzean A.J. S., Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br. Med. J. 1: 451, 1967.
Glynn M.F., Talso P.J., Oester Y.T. Studies in familial periodic paralysis. Clin. Res. 10: 226, 1962 (Abstract).
Forman B.H. Hypokalemic periodic paralysis. J. A.M.A. 216: 146, 1971.
Corbett V.A., Nuttal F.Q. Familial hypokalemic periodic paralysis in Blacks. Ann. Intern. Med. 83: 63, 1975.
Jackman R.L., Jones R.E. Hyperthyroidism and periodic paralysis. Arch. Intern. Med. 113: 657, 1964.
Layzer R.B. Periodic paralysis and the sodium-potassium pump. Ann. Neurol. 11: 547, 1982.
Feely J. Potassium shift in thyrotoxic periodic paralysis. Postgrad. Med. J. 57: 238, 1981.
Okinaka S., Ohsawa N., Shizume K., Motohashi K., Fujita T., Murakawa S., Morii H., Uchikawa T. Effect of aldosterone antagonist (SC 9420) on periodic paralysis. J. Clin. Endocrinol. Metab. 22: 549, 1962.
Kabadi U.M. Corticotropin-induced hyperaldosteroism: causing hypokalemic paralysis of thyrotoxicosis. N. Y. State J. Med. 80: 1860, 1980.
Resnick J. S., Dorman J. D., Engel W.K. Thyrotoxic periodic paralysis. Am. J. Med. 47: 831, 1969.
Streeten D.H.P., Speller P.J. The role of mineralocorticoids in the pathogenesis of hypokalemic periodic paralysis. J. Clin. Endocrinol. Metab. 39: 326, 1974.
Ramsay I. Thyrotoxic periodic paralysis. In: Ramsay I., Thyroid disease and muscle dysfunction. Year Book Medical Publishers, Chicago, 1974, p. 96.
McFadzean A.J.S., Yeung R. Familial occurrence of thyrotoxic periodic paralysis. Br. Med. J. 1: 760, 1969.
Yeo P.P.B., Chan S.F., Lui K.H., Wee G.B., Lim P., Cheah J. S. HLA and thyrotoxic period paralysis. Br. Med. J. 2: 930, 1978.
Valenta L.J., Treadwell T., Berry R., Elias A.N. Idiopathic thrombocytopenic purpura and Graves’ dis ease. Am. J. Hematol. 12: 69, 1982.
Albert E., Gotze D. The major histocompatibility system in man. In: Gotze D. (Ed.), The major histocompatibility system in man and animals. Springer-Verlag, New York, 1977, p. 7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kelly, T.M., Fishman, L.M. Thyrotoxic periodic paralysis in a Black male. J Endocrinol Invest 7, 517–519 (1984). https://doi.org/10.1007/BF03348460
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348460